文献速递产科母胎医学

基于智能手机的每日反馈系统对妊娠期糖尿病女性依从性、血糖控制、满意度及妊娠结局的影响:一项随机对照试验

The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled trial.
PubMed 文献 · Am J Obstet Gynecol · 2018-02-07

这项前瞻性单中心随机对照试验纳入120例新诊断妊娠期糖尿病(GDM)患者,比较常规每两周产检与通过智能手机应用每日反馈依从性和血糖控制的差异。智能手机组依从性更高(84±0.16% vs 66±0.28%,P<.001),平均血糖更低(105.1±8.6 mg/dL vs 112.6±7.4 mg/dL,P<.001),需要胰岛素治疗的比例更低(13.3% vs 30.0%,P=.044),且患者满意度高。

要点

  • 智能手机每日反馈组依从性84±0.16% vs 对照组66±0.28%,P<.001。
  • 智能手机组平均血糖105.1±8.6 mg/dL vs 对照组112.6±7.4 mg/dL,P<.001。
  • 智能手机组需胰岛素治疗比例13.3% vs 对照组30.0%,P=.044。

核心结论

  • 在GDM患者与多学科糖尿病妊娠门诊团队之间引入基于智能手机的每日反馈与沟通平台,改善了患者依从性和血糖控制,并降低了胰岛素治疗率。

研究设计与样本

  • 前瞻性、单中心、随机对照试验,纳入新诊断GDM患者120例,随机分为常规每两周产检对照组和通过智能手机应用每日详细反馈的智能手机组。

主要发现

  • 智能手机组依从性84±0.16% vs 对照组66±0.28%,P<.001。
  • 智能手机组平均血糖105.1±8.6 mg/dL vs 对照组112.6±7.4 mg/dL,P<.001。
  • 智能手机组空腹偏离目标测量率4.7±0.4% vs 对照组8.4±0.6%,P<.001;餐后1小时偏离目标测量率7.7±0.8% vs 对照组14.3±0.8%,P<.001。
  • 智能手机组需要胰岛素治疗的妊娠比例13.3% vs 对照组30.0%,P=.044。
  • 巨大儿、新生儿低血糖、肩难产及其他分娩和新生儿并发症发生率两组间无差异。

关键数值与推荐

  • 主要结局患者依从性定义为实际血糖测量次数/指导测量次数×100。
  • 研究基于初步阶段显示的70%基线血糖测量依从性,有足够把握度检测20%的依从性差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient compliance and tight glycemic control have been demonstrated to improve outcome in pregnancies complicated by gestational diabetes mellitus. The use of advanced technological tools, including smartphone-based platforms, to improve medical care and outcomes has been demonstrated in various fields of medicine, but only a few small studies were performed with gestational diabetes mellitus patients. OBJECTIVE: We aimed to study the impact of introducing a smartphone-based daily feedback and communication platform between gestational diabetes mellitus patients and their physicians, on patient compliance, glycemic control, pregnancy outcome, and patient satisfaction. STUDY DESIGN: This is a prospective, single-center, randomized controlled trial. Newly diagnosed gestational diabetes mellitus patients presenting to our multidisciplinary diabetes-in-pregnancy clinic were randomized to: (1) routine biweekly prenatal clinic care (control group); or (2) additional daily detailed feedback on their compliance and glycemic control from the clinic team via an application installed on their smartphone (smartphone group). The primary outcome was patient compliance defined as the actual blood glucose measurements/instructed measurements ×100. The secondary outcomes included diabetes-control parameters, pregnancy, and neonatal outcomes. The study was adequately powered to detect a 20% difference in patient compliance, based on a preliminary phase that demonstrated 70% baseline compliance to glucose measurements. RESULTS: A total of 120 newly diagnosed gestational diabetes mellitus patients were analyzed. The 2 groups did not differ in terms of age, parity, education, body mass index, family history, maternal comorbidities, oral glucose tolerance test values, and hemoglobin A1C at randomization. The smartphone group demonstrated higher level of compliance (84 ± 0.16% vs 66 ± 0.28%, P < .001); lower mean blood glucose (105.1 ± 8.6 mg/dL vs 112.6 ± 7.4 mg/dL, P < .001); lower rates of off-target measurements both fasting (4.7 ± 0.4% vs 8.4 ± 0.6%, P < .001) and 1-hour postprandial (7.7 ± 0.8% vs 14.3 ± 0.8%, P < .001); and a lower rate of pregnancies requiring insulin treatment (13.3% vs 30.0%, P = .044). The rates of macrosomia, neonatal hypoglycemia, shoulder dystocia, and other delivery and neonatal complications did not differ between the groups. Patients in the smartphone group reported excellent satisfaction from the use of the application and from their overall prenatal care. CONCLUSION: Introduction of a smartphone-based daily feedback and communication platform between gestational diabetes mellitus patients and the multidisciplinary diabetes-in-pregnancy clinic team improved patient compliance and glycemic control, and lowered the rate of insulin treatment.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Miremberg H, Ben-Ari T, Betzer T, et al. The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled trial. Am J Obstet Gynecol. 2018. PMID: 29425836. doi:10.1016/j.ajog.2018.01.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。